Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver

Toxicological Sciences

Volumn 94, Issue 2, 2006, Pages 388-397

  He, Quanren ^a,b   Suzuki, Hirofumi ^a   Sharma, Neelesh ^a   Sharma, Raghubir P ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NONE   (United States)

Author keywords

Fumonisin; Serine palmitoyltransferase; Sphingolipid; Sphingomyelinase; Sphingosine kinase

Indexed keywords

FUMONISIN B1; PARACETAMOL; SERINE PALMITOYLTRANSFERASE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE ACYLTRANSFERASE; SPHINGOSINE KINASE;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME METABOLISM; ENZYME SYNTHESIS; FEMALE; LIVER METABOLISM; LIVER REGENERATION; LIVER TOXICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; FUMONISINS; HEPATITIS, TOXIC; INJECTIONS, SUBCUTANEOUS; ISOENZYMES; LIVER; MICE; MICE, INBRED C57BL; MYCOTOXINS; OXIDOREDUCTASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SERINE C-PALMITOYLTRANSFERASE; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

GIBBERELLA MONILIFORMIS; SPHINGOIDEA;

EID: 33751423864     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl102     Document Type: Article

References (36)

1. Albi, E., Peloso, I., and Viola Magni, M. P. (1999). Nuclear membrane sphingomyelin-cholesterol changes in rat liver after hepatectomy. Biochem. Biophys. Res. Commun. 262, 692-695.
2. 1-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. Toxicology 172, 81-92.
3. Hanada, K. (2003). Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta 1632, 16-30.
4. Hannun, Y. A., Luberto, C., and Argraves, K. M. (2001). Enzymes of sphingolipid metabolism: From modular to integrative signaling. Biochemistry 40, 4893-4903.
5. 1 despite increasing accumulation of free sphingoid bases. Toxicol. Sci. 80, 335-342.
6. He, Q., Riley, R. T., and Sharma, R. P. (2001). Fumonisin-induced tumor necrosis factor-α expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition. Toxicol. Appl. Pharmacol. 174, 69-77.
7. He, X., Chen, F., McGovern, M. M., and Schuchman, E. H. (2002). A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism. Anal. Biochem. 306, 115-123.
8. 1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ. Health Perspect. 109(Suppl. 2), 277-282.
9. 1 in the F344/N/Nctr BR rat. Environ. Health Perspect. 109(Suppl. 2), 309-314.
10. 1. Chem.-Biol. Interact. 145, 297-309.
11. 1-induced apoptosis. Environ. Health Perspect. 109(Suppl. 2), 315-320.
12. Le Stunff, H., Galve-Roperh, I., Peterson, C., Milstien, S., and Spiegel, S. (2002). Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis. J. Cell. Biol. 158, 1039-1049.
13. 1. J. Biol. Chem. 274, 4607-4612.
14. Memon, R. A., Holleran, W. M., Moser, A. H., Seki, T., Uchida, Y., Fuller, J., Shigenaga, J. K., Grunfeld, C., and Feingold, K. R. (1998). Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler. Thromb. Vasc. Biol. 18, 1257-1265.
15. Merrill, A. H., Jr, Sullards, M. C., Wang, E., Voss, K. A., and Riley, R. T. (2001). Sphingolipid metabolism: Roles in signal transduction and disruption by fumonisins. Environ. Health Perspect. 109(Suppl. 2), 283-289.
16. 1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268, 27299-27306.
17. Merrill, A. H., Jr, Wang, E., Mullins, R. E., Jamison, W. C., Nimkar, S., and Liotta, D. C. (1988). Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal. Biochem. 171, 373-381.
18. Olivera, A., Barlow, K. D., and Spiegel, S. (2000). Assaying sphingosine kinase activity. Methods Enzymol. 311, 215-223.
19. Osawa, Y., Banno, Y., Nagaki, M., Brenner, D. A., Naiki, T., Nozawa, Y., Nakashima, S., and Moriwaki, H. (2001). TNF-α-induced sphingosine 1-phosphate inhibits apoptosis through a phosphatidylinositol 3-kinase/ Akt pathway in human hepatocytes. J. Immunol. 167, 173-180.
20. 1 in swine. Nat. Toxins 2, 73-80.
21. Prieschl, E. E., and Baumruker, T. (2000). Sphingolipids: Second messengers, mediators and raft constituents in signaling. Immunol. Today 21, 555-560.
22. Reiss, U., Oskouian, B., Zhou, J., Gupta, V., Sooriyakumaran, P., Kelly, S., Wang, E., Merrill, A. H., Jr, and Saba, J. D. (2004). Sphingosine-phosphate lyase enhances stress-induced ceramide generation and apoptosis. J. Biol. Chem. 279, 1281-1290.
23. Riley, R. T., Enongene, E., Voss, K. A., Norred, W. P., Meredith, F. I., Sharma, R. P., Spitsbergen, J., Williams, D. E., Carlson, D. B., and Merrill, A. H., Jr. (2001). Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect. 109(Suppl. 2), 301-308.
24. 1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J. Biol. Chem. 269, 3475-3481.
25. 1 in human embryonic kidney (HEK-293) cells. Chem.-Biol. Interact. 151, 33-42.
26. 1. J. Comp. Pathol. 117, 371-381.
27. Sharma, R. P., He, Q., and Johnson, V. J. (2003). Deletion of IFN-γ reduces fumonisin-induced hepatotoxicity in mice via alterations in inflammatory cytokines and apoptotic factors. J. Interferon Cytokine Res. 23, 13-23.
28. Spiegel, S., and Milstien, S. (2002). Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277, 25851-25854.
29. Thon, L., Mohlig, H., Mathieu, S., Lange, A., Bulanova, E., Winoto-Morbach, S., Schutze, S., Bulfone-Paus, S., and Adam, D. (2005). Ceramide mediates caspase-independent programmed cell death. FASEB J. 19, 1945-1956.
30. 1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J. Biochem. Mol. Toxicol. 12, 281-289.
31. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., and Merrill, A. H., Jr. (1991). Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266, 14486-14490.
32. Williams, R. D., Wang, E., and Merrill, A. H., Jr. (1984). Enzymology of long-chain base synthesis by liver: Characterization of serine palmitoyltransferase in rat liver microsomes. Arch. Biochem. Biophys. 228, 282-291.
33. 1. J. Biol. Chem. 270, 13171-13178.
34. Xia, P., Wang, L., Gamble, J. R., and Vadas, M. A. (1999). Activation of sphingosine kinase by tumor necrosis factor-α inhibits apoptosis in human endothelial cells. J. Biol. Chem. 274, 34499-34505.
35. Xia, P., Wang, L., Moretti, P. A., Albanese, N., Chai, F., Pitson, S. M., D'Andrea, R. J., Gamble, J. R., and Vadas, M. A. (2002). Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J. Biol. Chem. 277, 7996-8003.
36. Yoo, H. S., Norred, W. P., Showker, J., and Riley, R. T. (1996). Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol. Appl. Pharmacol. 138, 211-218.